Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1α, FASN, and mTORC1

Stem Cells ◽  
2015 ◽  
Vol 33 (7) ◽  
pp. 2182-2195 ◽  
Author(s):  
Hyun Jik Lee ◽  
Jung Min Ryu ◽  
Young Hyun Jung ◽  
Sang Yub Oh ◽  
Sei-Jung Lee ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Human Mesenchymal Stem Cells ◽  
And Migration ◽  
Proliferation And Migration

scholarly journals miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells

2013 ◽  
Vol 41 (21) ◽  
pp. 9753-9763 ◽  
Author(s):  
Jui-Yu Hsieh ◽  
Tse-Shun Huang ◽  
Shu-Meng Cheng ◽  
Wei-Shiang Lin ◽  
Tsung-Neng Tsai ◽  
...  
Keyword(s):  
Stem Cells ◽  
Cell Proliferation ◽  
Mesenchymal Stem Cells ◽  
Human Mesenchymal Stem Cells ◽  
Cell Proliferation And Migration ◽  
And Migration ◽  
Proliferation And Migration

Involvement of cationic channels in proliferation and migration of human mesenchymal stem cells

2012 ◽  
Vol 44 (6) ◽  
pp. 358-364 ◽  
Author(s):  
Fengfei Ding ◽  
Guibing Zhang ◽  
Lu Liu ◽  
Lizhong Jiang ◽  
Rui Wang ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Human Mesenchymal Stem Cells ◽  
Cationic Channels ◽  
And Migration ◽  
Proliferation And Migration

Migration of Human Mesenchymal Stem Cells is Stimulated by Low Shear Stress via MAPK Signaling

2012 ◽  
Author(s):  
Lin Yuan ◽  
Naoya Sakamoto ◽  
Guanbin Song ◽  
Masaaki Sato
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Human Mesenchymal Stem Cells ◽  
Mapk Signaling ◽  
Disease Treatment ◽  
Differentiation Potential ◽  
Multipotent Stem Cells ◽  
Low Shear Stress ◽  
Multipotent Differentiation ◽  
And Migration

Mesenchymal stem cells (MSCs) represent as multipotent stem cells which hold the abilities of self-renewal and give rise to cells of diverse lineages [1]. With their remarkable combination of multipotent differentiation potential and low immunogenicity, MSCs are considered to be an attractive candidate for cell-based tissue repair and regenerative tissue engineering [2, 3]. Increasing number of studies has demonstrated that mobilization and migration of injected MSCs to the damaged tissues is a key step for these cells to participate in disease treatment and tissue regeneration [4, 5].

scholarly journals Optimising proliferation and migration of mesenchymal stem cells using platelet products: A rational approach to bone regeneration

2019 ◽  
Vol 37 (6) ◽  
pp. 1329-1338 ◽  
Author(s):  
Katrina M. Moisley ◽  
Jehan J. El‐Jawhari ◽  
Heather Owston ◽  
Giuseppe Tronci ◽  
Stephen J. Russell ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Bone Regeneration ◽  
Rational Approach ◽  
And Migration ◽  
Proliferation And Migration

Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF

2016 ◽  
Vol 94 ◽  
pp. 32-42 ◽  
Author(s):  
Mansoreh Nazari ◽  
Nathan C. Ni ◽  
Ana Lüdke ◽  
Shu-Hong Li ◽  
Jian Guo ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Mast Cells ◽  
And Migration ◽  
Proliferation And Migration

scholarly journals Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1/2-MMP-9 pathway

2019 ◽  
Vol 316 (1) ◽  
pp. H233-H244 ◽  
Author(s):  
Yuan He ◽  
Yanjie Guo ◽  
Yunlong Xia ◽  
Yongzhen Guo ◽  
Rutao Wang ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Myocardial Ischemia ◽  
Matrix Metalloproteinase ◽  
Ischemia Reperfusion ◽  
Matrix Metalloproteinase 9 ◽  
Myocardial Ischemia Reperfusion ◽  
And Migration ◽  
Metalloproteinase 9 ◽  
Proliferation And Migration

Stem cell therapy is a potentially effective and promising treatment for ischemic heart disease. Resistin, a type of adipokine, has been found to bind to adipose-derived mesenchymal stem cells (ADSCs). However, the effects of resistin on cardiac homing by ADSCs and on ADSC-mediated cardioprotective effects have not been investigated. ADSCs were obtained from enhanced green fluorescent protein transgenic mice. C57BL/6J mice were subjected to myocardial ischemia-reperfusion (I/R) or sham operations. Six hours after the I/R operation, mice were intravenously injected with resistin-treated ADSCs (ADSC-resistin) or vehicle-treated ADSCs (ADSC-vehicle). Cardiac homing by ADSCs and cardiomyocyte apoptosis were investigated 3 days after I/R. Cardiac function, fibrosis, and angiogenesis were evaluated 4 wk after I/R. Cellular and molecular mechanisms were investigated in vitro using cultured ADSCs. Both immunostaining and flow cytometric experiments showed that resistin treatment promoted ADSC myocardial homing 3 days after intravenous injection. Echocardiographic experiments showed that ADSC-resistin, but not ADSC-vehicle, significantly improved left ventricular ejection fraction. ADSC-resistin transplantation significantly mitigated I/R-induced fibrosis and reduced atrial natriuretic peptide/brain natriuretic peptide mRNA expression. In addition, cardiomyocyte apoptosis was reduced, whereas angiogenesis was increased by ADSC-resistin treatment. At the cellular level, resistin promoted ADSC proliferation and migration but did not affect H2O2-induced apoptosis. Molecular experiments identified the ERK1/2-matrix metalloproteinase-9 pathway as a key component mediating the effects of resistin on ADSC proliferation and migration. These results demonstrate that resistin can promote homing of injected ADSCs into damaged heart tissue and stimulate functional recovery, an effect mediated through the ERK1/2 signaling pathway and matrix metalloproteinase-9. NEW & NOTEWORTHY First, intravenous injection of adipose-derived mesenchymal stem cells (ADSCs) treated with resistin significantly increased angiogenesis and reduced myocardial apoptosis and fibrosis in a murine model of ischemia-reperfusion, resulting in improved cardiac performance. Second, resistin treatment significantly increased myocardial homing of intravenously delivered ADSCs. Finally, the ERK1/2-matrix metalloproteinase 9 pathway contributed to the higher proliferative and migratory capacities of ADSCs treated with resistin.

Sign in / Sign up

Export Citation Format

Share Document